The Synergistic Meeting on Oligonucleotide Therapeutics, IV SMOT, is a premier event that unites leading experts, researchers, entrepreneurs, and industry pioneers in the field of therapeutic oligonucleotides. Our mission is to drive collaboration, spark innovation, and showcase the latest breakthroughs shaping the future of oligonucleotide therapies.

This year, they place a special focus on Innovative Delivery Solutions, exploring cutting-edge approaches that are transforming the way these therapies reach their targets.

Join our presentation “A CMC perspective on Oligonucleotide drug delivery” on February 28, by Daniel Bachmann, Business Development Manager at Bachem.